Literature DB >> 16630723

Design and evaluation of new antipsoriatic antedrug candidates having 16-en-22-oxa-vitamin D3 structures.

Kazuki Shimizu1, Akira Kawase, Tsuyoshi Haneishi, Yasuharu Kato, Kazutomo Kinoshita, Masayuki Ohmori, Yoshiyuki Furuta, Takashi Emura, Nobuaki Kato, Tetsuya Mitsui, Koji Yamaguchi, Keiichi Morita, Nobuo Sekiguchi, Tessai Yamamoto, Tomochika Matsushita, Shin Shimaoka, Atsuko Sugita, Kazumi Morikawa.   

Abstract

Design, synthesis, and in vitro and in vivo evaluation of a series of antipsoriatic antedrugs having 16-en-22-oxa-vitamin D3 are described. Among the seven compounds examined, two are promising: ester 5c and amide 5f, both of which exhibit greater potent antiproliferation activity with lessened calcemic activity than the presently prescribed maxacalcitol (2).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630723     DOI: 10.1016/j.bmcl.2006.03.014

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Giemsa-stained pseudo-micronuclei in rat skin treated with vitamin D3 analog, pefcalcitol.

Authors:  Akira Takeiri; Kenji Tanaka; Asako Harada; Kaori Matsuzaki; Mariko Yano; Shigeki Motoyama; Chie Katoh; Masayuki Mishima
Journal:  Genes Environ       Date:  2017-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.